Coag review Flashcards

(44 cards)

1
Q

PTT or aPTT evaluates for which pathway? Used to monitor what therapy

A
  • intrinsic and common pathways
  • used to monitor unfractionated heparin therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PT evaluates for which pathway? Used to monitor what therapy

A
  • extrinsic and common
  • used to monitor Warfarin (coumadin) therapy
    • vitamin K dependent clotting factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which factors are part of the intrinsic pathway

A
  • 8, 9, 11, 12
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which factors are part of the extrinsic pathway

A
  • tissue factor
  • VII
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is present in common pathway

A
  • prothrombin (II)
  • Thrombin (IIa)
  • fibrinogen (I)
  • V
  • X
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

target INR therapy for DVT (prophylaxis)

A

1.8-2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

target INR therapy for venous thromboembolism and AFIB

A

2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

target INR therapy for mechanical heart valves

A

2.5-3.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hemophilia A

A

factor VIII deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how does liver cirrhosis cause thrombocytopenia

A
  • liver cirrhosis -> portal HTN -> splenomegaly -> splenic sequestration -> thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is platelet dysfunction and what causes it? Treatment?

A
  • impaired adherence or aggregation of platelets
  • acquired: more common
    • liver disease, von willebrand disease, myeloproliferative disease, drugs
  • treatment:
    • treat underlying cause
    • platelet transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name conditions that cause increased destruction of platelets

A
  • ITP
  • DIC
  • heparin-induced thrombocytopenia (HIT)
  • thrombotic microangiopathies
    • TTP
    • HUS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is heparin-induced thrombocytopenia (HIT)

A
  • new onset thrombocytopenia/thrombus while on heparin therapy
  • will occur 5-10 days after putting someone on heparin; patient develops antibodies that bind to platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

thrombotic thrombocytopenic purpura (TTP) is more common in males or females

A

females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

etiology of thrombotic thrombocytopenic purpura (TTP)

A
  • inherited or idiopathic
    • deficiency or antibodies ADAMST-13
  • drugs, pregnancy, HIV infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

explain what happens in thrombotic thrombocytopenic purpura (TTP)

A
  • ADAMTS-13 is responsible for cleaving vWF into a smaller molecule, so without it, platelets aggregate around huge vWF and leads to clots and low platelet levels in blood
  • microthrombi are formed throughout the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Name the Pentad of symptoms associated with thrombotic thrombocytopenic purpura (TTP)

A
  • microangiopathic hemolytic anemia
  • thrombocytopenia
  • acute kidney injury
  • neurologic defects
  • fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

treatment of thrombotic thrombocytopenic purpura (TTP)

A

plasma exchange

19
Q

hemolytic uremic syndrome typically seen in what patient population

20
Q

etiology of hemolytic uremic syndrome

A

Ecoli O157:H7

21
Q

name Triad of symptoms seen in hemolytic uremic syndrome

A
  • microangiopathic hemolytic anemia
  • thrombocytopenia
  • acute kidney injury
  • **most cases preceeded by bloody diarrhea
22
Q

treatment of hemolytic uremic syndrome in adults

A

plasma exchange

23
Q

treatment of hemolytic uremic syndrome in children

A
  • IV fluid and electrolyte repletion
  • dialysis if indicated
24
Q

typical of what conditions

  • microangiopathic hemolytic anemia
    • fragmented RBC: schistocytes: helmet cells
25
clinical findings are associated with this condition * increased indirect biliruben * decreased serum haptoglobin (binds to iron to preserve it) * negative coombs test * thrombocytopenia * PT and aPTT are normal * acute kidney injury * microangiopathic hemolytic anemia
* TTP * HUS
26
name nutritional causes of impaired production of platelets
* Vitamin B12, folate deficiency * alcohol * direct toxicity to bone marrow * hypersplenism secondary to liver disease
27
List the anticoagulants that are available for use
* IV unfractionated heparin (UFH) * LMWH * oral warfarin * factor Xa inhibitors * oral direct thrombin inhibitors
28
Contraindications to anticoagulation
* pregnancy * risk of hemorrhage \> than the potential clinical benefits of therapy
29
function of warfarin
* inhibits conversion of vitamin K to active form * depletion of vit K dependent clotting factors (2, 7, 9, 10) * inhibits Protein C and Protein S * inhibits propagation - does not remove thrombus
30
indications for use of warfarin
* prophylaxis/treatment * VTE * AFIB * prosthetic heart valve * stroke * post MI
31
when should warfarin treatment by initiated? Initial dose?
* initiated on **day 1 or day 2 of heparin** * initial dose: \< or = **5 mg/day**
32
lower initiation doses of warfarin are recommended for
* elderly * liver disease * malnourished
33
warfarin requires on average how many days before full anticoagulation effect in achieved? peak effect of warfarin occurs when?
* requires 2-3 days before full effect * peak effect of drug: after 48 hours
34
Treatment for patients with acute DVT of leg requires warfarin **bridge therapy**. describe this
* parental therapy (heparin) should overlap with warfarin for a minimum of **5 days** AND until the INR is 2.0 or above for at least 24 hours
35
what is a normal INR for a patient who is NOT anticoagulated
1.0
36
patients on warfarin should be monitored how often?
* daily and then weekly * once stabilized, every 2-4 weeks
37
hemorrhagic risk becomes dominant at an INR greater than
4
38
no warfarin efficacy below INR of ? Efficacy diminished when INR is ?
* no efficacy: \< 1.5 * diminished efficacy: \< 2.0
39
what common drug can cause decreased warfarin effect
oral contraceptive
40
food sources of vit K
* cauliflower * green leafy vegetables * spinach
41
what is given for supratherapeutic INR (non urgent)
vitamin K (oral, SC, or IV) * will take 6-24 hours to correct INR
42
what is given for supratherapeutic INR ( urgent)
* 10 mg vitamin K (IV) * fresh frozen plasma * prothrombin complex concentrate (PCC) * recombinant factor VII
43
time to anticoagulation reversal following discontinuation of warfarin
5-14 days
44